Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Friday, October 10, 2008, 9:02PM ET - U.S. Markets Closed. Dow Down 1.49% Nasdaq Up 0.27%
Medtronic, Inc. (MDT)At 4:07PM ET: 40.00  Down 1.95 (4.65%)  
MORE ON MDT
Quotes
Charts
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials

ProfileGet Profile for:
Medtronic, Inc.
710 Medtronic Parkway
Minneapolis, MN 55432
United States - Map
Phone: 763-514-4000
Fax: 763-514-4879
Web Site: http://www.medtronic.com

DETAILS 
Index Membership:S&P 100
S&P 500
S&P 1500 Super Comp
Sector:Healthcare
Industry:Medical Appliances & Equipment
Full Time Employees:40,351

BUSINESS SUMMARY 
Medtronic, Inc. develops, manufactures, and markets medical devices worldwide. The company’s Cardiac Rhythm Disease Management segment primarily offers pacemakers, implantable defibrillators, leads, ablation products, electrophysiology catheters, insertable cardiac monitors, and information systems for cardiac rhythm disease management. Its Spinal segment provides thoracolumbar, cervical, and interbody spinal devices; bone growth substitutes; and devices for vertebral compression fractures and spinal stenosis. The CardioVascular segment offers coronary and peripheral stents, and related delivery systems; endovascular stent graft systems; heart valve replacement technologies and tissue ablation systems; and open heart and coronary bypass grafting surgical products. The Neuromodulation segment provides therapeutic and diagnostic devices, including implantable neurostimulation systems, implantable drug delivery devices, and urology and gastroenterology products. The Diabetes segment offers external insulin pumps and related consumables, continuous glucose monitoring systems, and subcutaneous glucose sensors. The Surgical Technologies segment provides products to treat conditions of the ear, nose, and throat, as well as certain neurological disorders. It offers powered tissue-removal systems and other microendoscopy instruments, implantable devices, nerve monitoring systems, disposable fluid-control products, hydrocephalus shunt devices, external drainage systems, cranial fixation devices, neuroendoscopes, dura repair products, image-guided surgery systems, and a Ménière’s disease therapy device. The Physio-Control segment offers external defibrillators, including manual defibrillator/monitors used by hospitals and emergency response personnel, and automated external defibrillators used in commercial and public settings; and related data management solutions and support services. The company was founded in 1949 and is headquartered in Minneapolis, Minnesota.
Key Statistics

COMPANY WEBSITES 
  • Home Page
  • Search Yahoo! for:
    More on Medtronic, Inc.


    CORPORATE GOVERNANCE 
    Medtronic, Inc.'s Corporate Governance Quotient (CGQ®) as of 1-Oct-08 is better than 61.3% of S&P 500 companies and 94.8% of Health Care Equipment & Services companies.
    Brought to you by Institutional Shareholder Services.

    KEY EXECUTIVES 
     PayExercised
    Mr. William A. Hawkins III, 53
    Chairman and Chief Exec. Officer
    $ 1.97M $ 0
    Mr. Gary Ellis , 50
    Chief Financial Officer, Principal Accounting Officer and Sr. VP
    $ 1.02M $ 594.00K
    Mr. Jean-Luc Butel , 50
    Sr. VP and Pres of International
    $ 824.00K $ 0
    Mr. Stephen H. Mahle , 61
    Exec. VP of Healthcare Policy & Regulatory
    $ 1.11M $ 995.00K
    Mr. H. James Dallas , 49
    Sr. VP of Quality & Operations and Member of Operating Committee
    N/A N/A
    Dollar amounts are as of 31-Dec-08 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.
    View Insiders


    Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
    Get Profile for Another Symbol: Symbol Lookup
    Annual ReportsSector Analysis